Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 115 of 297
- RecruitingPhase 1/Phase 2
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
Akouos, Inc.
- Location
- Baltimore, MD + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Op-T LLC
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Ages 18–50
- RecruitingPhase 4
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
CARE ARTHRITIS LTD.
- Location
- Cleveland, OH + 2 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous Leg Ulcers (VLUs)
Organogenesis
- Location
- Pickerington, OH
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Merck Sharp & Dohme LLC
- Location
- Ann Arbor, MI + 3 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery
NeuroAEye LLC
- Location
- Cedar Rapids, IA + 1 other US site
- Eligibility basics
- Ages 21–80
- RecruitingPhase 3
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in…
AION Healthspan, Inc.
- Location
- Miami, FL + 1 other US site
- Eligibility basics
- Ages 35–75
- RecruitingPhase 3
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
Novadip Biosciences
- Location
- Phoenix, AZ + 3 other US sites
- Eligibility basics
- Up to age 17
- Recruiting
Neuralert Stroke Monitor Trial
Neuralert Technologies LLC
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 22+
- Recruiting
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
SeaStar Medical
- Location
- Ann Arbor, MI
- Eligibility basics
- Ages 18+
- Recruiting
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Cerus Endovascular, Inc.
- Location
- Park Ridge, IL + 8 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
ECM Therapeutics, Inc.
- Location
- Lebanon, NH + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Galderma R&D
- Location
- Ann Arbor, MI + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
BioMarin Pharmaceutical
- Location
- Phoenix, AZ + 6 other US sites
- Eligibility basics
- Ages 0 mo–3
- RecruitingPhase 3
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
- Location
- Dothan, AL
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
RECORDATI GROUP
- Location
- San Francisco, CA + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Tucson, AZ + 36 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 2
Remotely Observed Methadone Evaluation II
Sonara Health
- Location
- Chicago, IL
- Eligibility basics
- Ages 18–64
- RecruitingPhase 3
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Biomed Industries, Inc.
- Location
- Phoenix, AZ + 13 other US sites
- Eligibility basics
- Ages 5–20 · Women only
- RecruitingPhase 1/Phase 2
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
United Therapeutics
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 40–70
- RecruitingPhase 1
A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
Climb Bio, Inc.
- Location
- Allen, TX + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
Iterum Therapeutics, International Limited
- Location
- Little Rock, AR
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Italfarmaco
- Location
- Redlands, CA + 12 other US sites
- Eligibility basics
- Ages 18+
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies